Literature DB >> 11806714

Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.

Zu D Liu1, Reem Kayyali, Robert C Hider, John B Porter, Anthony E Theobald.   

Abstract

A range of novel 3-hydroxypyridin-4-ones with different R(2) substitutents has been synthesized for the investigation of the structure-activity relationship between the chemical nature of the ligand and the inhibitory activity of the iron-containing metalloenzyme 5-lipoxygenase. Results indicate that the molecular dimensions, together with the lipophilicity, have a critical impact on the ability of this class of chelator to inhibit 5-lipoxygenase. Hydrophilic ligands with a bulky R(2) substitutent tend to be weak inhibitors; thus 1,6-dimethyl-2-(4'-N-n-propylsuccinamido)methyl-3-hydroxypyridin-4(1H)-one (22b) which has the largest R(2) substitutent only caused 2% inhibition of the enzyme activity after 30 min incubation at 110 microM IBE (iron-binding equivalents), as compared with deferiprone which caused 40% inhibition of the enzyme activity, under the same conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11806714     DOI: 10.1021/jm010817i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

Review 2.  The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.

Authors:  Alessandra Gaeta; Robert C Hider
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 3.  Iron homeostasis and eye disease.

Authors:  Allison Loh; Majda Hadziahmetovic; Joshua L Dunaief
Journal:  Biochim Biophys Acta       Date:  2008-11-14

4.  Design of a Water Soluble Fluorescent 3-Hydroxy-4-Pyridinone Ligand Active at Physiological pH Values.

Authors:  Andreia Leite; Ana M G Silva; Catarina Coutinho; Luís Cunha-Silva; Baltazar de Castro; Maria Rangel
Journal:  J Fluoresc       Date:  2016-06-29       Impact factor: 2.217

5.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

6.  Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties.

Authors:  Ana Nunes; Maria Podinovskaia; Andreia Leite; Paula Gameiro; Tao Zhou; Yongmin Ma; Xiaole Kong; Ulrich E Schaible; Robert C Hider; Maria Rangel
Journal:  J Biol Inorg Chem       Date:  2010-04-03       Impact factor: 3.358

7.  Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.

Authors:  Lissette R Perez; Katherine J Franz
Journal:  Dalton Trans       Date:  2009-12-17       Impact factor: 4.390

8.  Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development.

Authors:  Darpan N Pandya; Nikunj Bhatt; Hong Yuan; Cynthia S Day; Brandie M Ehrmann; Marcus Wright; Ulrich Bierbach; Thaddeus J Wadas
Journal:  Chem Sci       Date:  2016-12-13       Impact factor: 9.825

9.  Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89.

Authors:  Nikunj B Bhatt; Darpan N Pandya; Jide Xu; David Tatum; Darren Magda; Thaddeus J Wadas
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

10.  Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68.

Authors:  Cinzia Imberti; Samantha Y A Terry; Carleen Cullinane; Fiona Clarke; Georgina H Cornish; Nisha K Ramakrishnan; Peter Roselt; Andrew P Cope; Rodney J Hicks; Philip J Blower; Michelle T Ma
Journal:  Bioconjug Chem       Date:  2016-12-14       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.